GAB1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 3.53161944133262E-13 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
2.67330000025545E-07 |
Normal-vs-Stage2 |
1.50369999996069E-06 |
Normal-vs-Stage3 |
1.88737914186277E-15 |
Normal-vs-Stage4 |
1.62636570877339E-12 |
Stage1-vs-Stage2 |
1.353020E-01 |
Stage1-vs-Stage3 |
1.5948999999571E-06 |
Stage1-vs-Stage4 |
1.16149999951354E-07 |
Stage2-vs-Stage3 |
1.448570E-01 |
Stage2-vs-Stage4 |
4.171900E-02 |
Stage3-vs-Stage4 |
3.540000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
2.72804001610893E-12 |
Normal-vs-AfricanAmerican |
1.58910000047641E-07 |
Normal-vs-Asian |
5.758200E-02 |
Caucasian-vs-AfricanAmerican |
7.241000E-01 |
Caucasian-vs-Asian |
5.872800E-01 |
AfricanAmerican-vs-Asian |
5.182400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
6.87561119150359E-13 |
Normal-vs-Female |
8.02879984718174E-10 |
Male-vs-Female |
1.823350E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
7.63129999999945E-05 |
Normal-vs-Age(41-60Yrs) |
1.05160000041238E-07 |
Normal-vs-Age(61-80Yrs) |
1.62525548574877E-12 |
Normal-vs-Age(81-100Yrs) |
3.96430000049186E-07 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.231000E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.606600E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.116000E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.198200E-03 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.617600E-02 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.513600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
5.159600E-01 |
Normal-vs-Grade 2 |
3.66410000000039E-05 |
Normal-vs-Grade 3 |
3.47388784405211E-13 |
Normal-vs-Grade 4 |
<1E-12 |
Grade 1-vs-Grade 2 |
1.517170E-01 |
Grade 1-vs-Grade 3 |
3.62139999999789E-05 |
Grade 1-vs-Grade 4 |
5.00329999653104E-08 |
Grade 2-vs-Grade 3 |
5.05269999950819E-07 |
Grade 2-vs-Grade 4 |
1.03117514527185E-12 |
Grade 3-vs-Grade 4 |
9.71520000000448E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
9.73640000000442E-05 |
Normal-vs-ccB subtype |
1.63180580159406E-12 |
ccA subtype-vs-ccB subtype |
1.49500000157232E-08 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
2.45769959938968E-10 |
Normal-vs-N1 |
9.14589999956306E-07 |
N0-vs-N1 |
6.083800E-02 |
|
|